Replies to post #383679 on Innovation Pharmaceuticals Inc (IPIX)

[Brinjal]

The Brilacidin arm and the placebo arm had 60 patients each. 2/3rd (40 patients) in the Brilacidin arm received a 5-day course, and 1/3rd (20 patients) a 3-day course (this was announced previously). 4 in the Brilacidin arm died, and ditto in the placebo arm. That's the reason for the conclusion that there was no change in mortality.

The way the PR is worded is a little confusing.

[Lemoncat]

Don't over think it Jitz. Hopefully the full data will be released and there will be some positive secondary endpoints in there.

If the company could have spun these results in any positive light they would have.

Go IPIX!

[kfcyahoo]

I believe there were 60 patients in each arm (60 B, 60placebo)

.0667 x 60 ~ 4.0